Virus Genes

, Volume 54, Issue 4, pp 475–483 | Cite as

The expression and role of lncRNA AX800134 in hepatitis B virus-related hepatocellular carcinoma

  • Kai Zuo
  • Li Kong
  • Dong Xue
  • Yanyan Yang
  • Linlin Xie


Chronic infection with hepatitis B virus (HBV) is one of most important risk factors for the development of hepatocellular carcinoma (HCC). Several long non-coding RNAs (lncRNAs) have been shown to be involved in the etiology of HBV-related HCC. AX800134 is one recently identified lncRNA associated with HCC. In this study, we validated the upregulated expression of AX800134 in HBV-positive HCC compared with HBV-negative HCC. Furthermore, we found that HBV X protein (HBx) directly triggered AX800134 expression in human hepatoma HepG2 cells. Pro-inflammatory cytokine TNFα also induced AX800134 upregulation in HBx-expressing HepG2 cells, which could be reversed by reactive oxygen species (ROS) scavenger pyrrolidine dithiocarbamate (PDTC). Additionally, silencing AX800134 with siRNA interference remarkably inhibited the growth and invasion of HBx-expressing HepG2 cells. AX800134 antagonism also enhanced spontaneous apoptosis of HepG2 cells under serum deprivation condition. Therefore, our results indicate that highly expressed AX800134 acts as an oncogenic factor in HCC, and its upregulation is related with the viral product HBx and chronic inflammation.


Long non-coding RNA AX800134 Hepatitis B virus Hepatocellular carcinoma 



Prof. Zhiqiang Liu (Department of Pathology and Pathophysiology, Tianjin Medical University) is gratefully acknowledged for editing the manuscript.

Author contributions

ZK designed and supervised the study; ZK, KL, and XD did laboratory testing; YYY and XLL provided the patients’ samples. ZK drafted the manuscript, and all authors contributed to review and revision.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

This study was approved by the ethics committee of Binzhou People’s Hospital, China. This study was done in accordance with the Declaration of Helsinki, Good Clinical Practice, and Chinese regulatory requirements.


  1. 1.
    N.P. Nelson, P.J. Easterbrook, B.J. McMahon, Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin. Liver Dis. 20, 607–628 (2016)CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    A. Wasley, D. Kruszon-Moran, W. Kuhnert, E.P. Simard, L. Finelli et al., The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J. Infect. Dis. 202, 192–201 (2010)CrossRefPubMedGoogle Scholar
  3. 3.
    C. Xu, W. Zhou, Y. Wang, L. Qiao, Hepatitis B virus-induced hepatocellular carcinoma. Cancer Lett. 345, 216–222 (2014)CrossRefPubMedGoogle Scholar
  4. 4.
    M. Levrero, J. Zucman-Rossi, Mechanisms of HBV-induced hepatocellular carcinoma. J. Hepatol. 64, S84–S101 (2016)CrossRefPubMedGoogle Scholar
  5. 5.
    S. Liu, S.S. Koh, C.G. Lee, Hepatitis B virus X protein and hepatocarcinogenesis. Int. J. Mol. Sci. 17. (2016)Google Scholar
  6. 6.
    M. Geng, X. Xin, L.Q. Bi, L.T. Zhou, X.H. Liu, Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis. World J. Gastroenterol. 21, 10732–10738 (2015)CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    B. Moyo, S.A. Nicholson, P.B. Arbuthnot, The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma. Virus Res. 212, 103–113 (2016)CrossRefPubMedGoogle Scholar
  8. 8.
    L. Shi, F. Peng, Y. Tao, X. Fan, N. Li, Roles of long noncoding RNAs in hepatocellular carcinoma. Virus Res. 223, 131–139 (2016)CrossRefPubMedGoogle Scholar
  9. 9.
    K. Wang, W.X. Guo, N. Li, C.F. Gao, J. Shi et al., Serum LncRNAs profiles serve as novel potential biomarkers for the diagnosis of HBV-positive hepatocellular carcinoma. PLoS ONE 10, e0144934 (2015)CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    A.T. Lee, J. Ren, E.T. Wong, K.H. Ban, L.A. Lee et al., The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage. J. Biol. Chem. 280, 33525–33535 (2005)CrossRefPubMedGoogle Scholar
  11. 11.
    N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa et al., Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 62, 3939–3944 (2002)PubMedGoogle Scholar
  12. 12.
    Y. Jin, D. Wu, W. Yang, M. Weng, Y. Li et al., Hepatitis B virus X protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA. Virol. J. 14, 238 (2017)CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    W. Chung, M. Kim, S. de la Monte, L. Longato, R. Carlson et al., Activation of signal transduction pathways during hepatic oncogenesis. Cancer Lett. 370, 1–9 (2016)CrossRefPubMedGoogle Scholar
  14. 14.
    M. Zhang, J. Gu, C. Zhang, Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes. Oncotarget 7, 7780–7800 (2016)PubMedPubMedCentralGoogle Scholar
  15. 15.
    X.X. Kong, Y.R. Lv, L.P. Shao, X.Y. Nong, G.L. Zhang et al., HBx-induced MiR-1269b in NF-kappaB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells. J. Transl. Med. 14, 189 (2016)CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    F. Kong, W. Hu, K. Zhou, X. Wei, Y. Kou et al., Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-kappaB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells. J. Exp. Clin. Cancer Res. 35, 172 (2016)CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    J.L. Huang, T.Y. Ren, S.W. Cao, S.H. Zheng, X.M. Hu et al., HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma. Oncotarget 6, 33791–33804 (2015)PubMedPubMedCentralGoogle Scholar
  18. 18.
    J.J. Hu, W. Song, S.D. Zhang, X.H. Shen, X.M. Qiu et al., HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci. Rep. 6, 23521 (2016)CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    W. Pan, H. Yu, S. Huang, P. Zhu, Resveratrol protects against TNF-alpha-induced injury in human umbilical endothelial cells through promoting sirtuin-1-induced repression of NF-KB and p38 MAPK. PLoS ONE 11, e0147034 (2016)CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    H. Takeda, A. Takai, T. Inuzuka, H. Marusawa, Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis. J. Gastroenterol. 52(1), 26–38 (2016)CrossRefPubMedGoogle Scholar
  21. 21.
    J. Lv, H.X. Fan, X.P. Zhao, P. Lv, J.Y. Fan et al., Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Cancer Lett. 382, 166–175 (2016)CrossRefPubMedGoogle Scholar
  22. 22.
    S.P. Li, H.X. Xu, Y. Yu, J.D. He, Z. Wang et al., LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget 7, 42431–42446 (2016)PubMedPubMedCentralGoogle Scholar
  23. 23.
    J. Wang, X. Liu, H. Wu, P. Ni, Z. Gu et al., CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 38, 5366–5383 (2010)CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    F. Wang, H.Q. Ying, B.S. He, Y.Q. Pan, Q.W. Deng et al., Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6, 7899–7917 (2015)PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Kai Zuo
    • 1
  • Li Kong
    • 2
  • Dong Xue
    • 3
  • Yanyan Yang
    • 2
  • Linlin Xie
    • 1
  1. 1.Department of Infectious DiseasesBinzhou People’s HospitalBinzhouChina
  2. 2.Department of Pharmacy Intravenous Admixture ServicesBinzhou People’s HospitalBinzhouChina
  3. 3.Department of Hepatobiliary SurgeryBinzhou People’s HospitalBinzhouChina

Personalised recommendations